GRAIL, Inc. (GRAL) Discusses PATHFINDER 2 Study Results and Clinical Program in Multi-Cancer Early Detection Transcript
Grail, Inc.(US:GRAL) Seeking Alphaยท2025-10-20 21:05PresentationGood day, ladies and gentlemen, and welcome to today's GRAIL analyst call. [Operator Instructions] Please be advised that this conference call is being recorded.Unknown Executive Thanks, operator, and thanks, everyone, for joining us today to discuss detailed PATHFINDER 2 study results presented over the weekend at ESMO. On this morning's call are Bob Ragusa, our Chief Executive Officer; Aaron Freidin, our Chief Financial Officer; Josh Ofman, President; Sir Harpal Kumar, President, Internationa ...